The new regulation will also bring changes to areas including research transparency and good clinical practice (GCP). Regarding research transparency, the MHRA said a legislative requirement would ...

The MHRA has kicked off an eight-week consultation ... safety reporting and good clinical practice (GCP), as well as sanctions and corrective measures if things go wrong. "We are proposing to ...

Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant. Breast cancer is the most common cancer and is one ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has today ... and benefit-risk profile of donanemab in routine clinical practice, particularly in relation to incidence and severity ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) expects the new UK clinical trial regulation to be implemented by January 2026. In a webinar on 15 October, MHRA chief ...